Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29738ed6201bf03fd623dd363809122d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate |
2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7370a0fa686d40ed19215a16753115d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81d756b7d44ca6ca507bc8922dd52553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cbb71715557f7a974b5bf3fb0effe37 |
publicationDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2016209969-A1 |
titleOfInvention |
Use of low molecular weight fractions of human serum albumin in treating diseases |
abstract |
The present invention provides a method of modulating various aspects of the immune system. In particular, the present invention teaches the use of diketopiperazines (DKPs) to modulate various aspects of the immune system such as, for example, inflammation, T-cells and various cytokines. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021163693-A1 |
priorityDate |
2015-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |